Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
25-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #58636
advertisement
Ayaki M
6
Showing records 1 to 6 |
Display all abstracts from
Ayaki M
125613
Presbyopia and associated factors specific to age groups
Ayaki M
Clinical and Experimental Optometry
2025; 0: 1-6
126441
Presbyopia Progression From the Age of 40 to 79 Years in Glaucoma Patients Treated With Prostaglandin F Receptor Agonists
Ayaki M
Translational vision science & technology
2025; 14: 25
125613
Presbyopia and associated factors specific to age groups
Hanyuda A
Clinical and Experimental Optometry
2025; 0: 1-6
126441
Presbyopia Progression From the Age of 40 to 79 Years in Glaucoma Patients Treated With Prostaglandin F Receptor Agonists
Hanyuda A
Translational vision science & technology
2025; 14: 25
125613
Presbyopia and associated factors specific to age groups
Negishi K
Clinical and Experimental Optometry
2025; 0: 1-6
126441
Presbyopia Progression From the Age of 40 to 79 Years in Glaucoma Patients Treated With Prostaglandin F Receptor Agonists
Negishi K
Translational vision science & technology
2025; 14: 25
Issue
25-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept